Anzeige
Mehr »
Dienstag, 17.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
316 Leser
Artikel bewerten:
(2)

Pulse Oximeter Market to Hit $7.03 Billion by 2032--Redefining Respiratory Monitoring in Modern Healthcare | MarketsandMarkets

DELRAY BEACH, Fla., July 9, 2025 /PRNewswire/ -- What's powering an $7.03 billion global pulse oximeter opportunity?

MarketsandMarkets Logo

The global pulse oximeters market, valued at US$3.59 billion in 2024, stood at US$3.92 billion in 2025 and is projected to advance at a resilient CAGR of 8.7% from 2025 to 2032, culminating in a forecasted valuation of US$7.03 billion by the end of the period. This growth is underpinned by the global surge in respiratory disorders, expanding elderly population, rising surgical volumes, and increased demand for non-invasive, real-time patient monitoring. For healthcare leaders and investors, pulse oximetry is no longer a peripheral tool-it's a frontline monitoring solution vital to quality care delivery and long-term cost containment.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=68168578

Why is pulse oximetry emerging as a clinical cornerstone in respiratory care?

Whether in high-acuity ICUs or home care settings, pulse oximeters provide essential oxygen saturation and heart rate insights. As chronic conditions like COPD and asthma rise globally, portable, wearable, and connected pulse oximeters are enabling continuous, actionable monitoring. These innovations reduce emergency visits, enable timely interventions, and align care pathways with value-based healthcare models-turning real-time monitoring into measurable outcomes.

What real-world problems do pulse oximeters solve?

From silent hypoxemia in respiratory diseases to complications from delayed diagnosis, pulse oximeters offer a proactive solution for hospitals, payors, and clinicians. They support continuous SpO2 and pulse rate monitoring in outpatient, inpatient, and home environments. The newest generation of Bluetooth and AI-enhanced devices allow seamless integration with EHRs, enabling better clinical decisions, fewer readmissions, and a more connected care ecosystem.

Where are the most investable growth regions?

Emerging economies-especially India, China, Brazil, and Southeast Asia-are becoming high-growth hotspots. These regions benefit from favorable demographics, increased government investment in health infrastructure, and growing awareness of chronic respiratory conditions. Additionally, global manufacturers are leveraging these markets for both cost-effective production and sales, driven by less stringent regulations and local demand for low-cost, reliable monitoring tools.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=68168578

Who's leading the pulse oximeter market-and who's gaining ground?

Medtronic holds the largest share (25-29%) with an extensive product lineup and global footprint. Masimo continues to lead with its proprietary SET® technology, dominating hospital contracts and remote monitoring integrations. Philips, Nonin Medical, Nihon Kohden, and GE Healthcare are expanding product portfolios in wearable and clinical-grade segments. New entrants and regional players like Lepu Medical and Contec are gaining traction through aggressive pricing and regional expansion strategies.

What are the market's pain points-and how do you unlock faster adoption?

Despite robust demand, adoption of pulse oximeters-especially OTC and low-cost models-is challenged by regulatory scrutiny and accuracy concerns. FDA advisories highlight the limitations of consumer-grade devices. To gain long-term trust, companies must invest in clinical validation, provider education, and compliance with evolving standards. Executive buy-in depends on clear ROI modeling, training programs, and proof of performance under real-world conditions.

So, what should healthcare executives and investors really be asking?
Not "Do we need pulse oximetry?"-but:

  • How can we embed pulse oximeters into our RPM (Remote Patient Monitoring) strategy?
  • Are our care models aligned with scalable, data-integrated oxygen monitoring solutions?
  • Can we validate device accuracy and demonstrate clinical ROI to stakeholders?
  • Which manufacturing and distribution partners can accelerate our presence in emerging economies?

Final Thought: Real-Time Monitoring. Real-World Impact.

In today's outcome-driven landscape, pulse oximeters offer more than vital sign tracking-they enable proactive, connected, and cost-effective care. Their role in surgical recovery, chronic disease management, and decentralized trials makes them indispensable to the future of healthcare delivery.

The pulse oximeter market is no longer in observation mode-it's in execution. Precision monitoring is the new frontline. The ROI is real. The market is ready.

For more information, Inquire Now!

Related Reports:

Surgical Sutures Market

Wound Care Market

Biosurgery Market

Knee Replacement Surgery Market

Surgical Suction Instruments Market

Get access to the latest updates on Top Companies in Pulse Oximeter and Pulse Oximeter Market Size

About MarketsandMarkets:

MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/pulse-oximeter-market-to-hit-7-03-billion-by-2032redefining-respiratory-monitoring-in-modern-healthcare--marketsandmarkets-302501057.html

© 2025 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.